“…These immature cells, known as myeloblasts or leukemia cells, crowd out healthy blood cells in the bone marrow (BM), decreasing the generation of red blood cells and white blood cells. AML is a heterogeneous disease, manifesting in various forms with genetic mutations and clinical outcomes ( Döhner and Döhner, 2008 , Testa et al, 2022 ). AML is the most common type of leukemia in adults, with over 20,000 new cases diagnosed each year in the USA alone ( De Kouchkovsky and Abdul-Hay, 2016 ).…”